Table 4.
Secondary clinical outcomes.
| HD (N = 279) | LD (N = 304) | Adjusted Risk ratio (95% CI) | P-value | ||
|---|---|---|---|---|---|
| Time until complete EN (days) | Mean (SD) | 11.12 (5.13) | 11.32 (5.6) | — | 0.924 |
| Time with central catheter (days) | Mean (SD) | 12.79 (11.01) | 13.12 (11.44) | — | 0.916 |
| Duration of hospital stay | Mean (SD) | 50.22 (19.98) | 53.06 (21.69) | — | 0.205 |
| Sepsis | N (%) | 53 (18.9) | 63 (20.7) | 1.00 (0.73, 1.37) | 0.994 |
| Bronchopulmonary dysplasia | N (%) | 51 (18.7) | 63 (20.7) | 0.88 (0.66, 1.17) | 0.374 |
| Patent ductus arteriosus | N (%) | 45 (16.1) | 69 (22.7) | 1.22 (0.88,1.68) | 0.237 |
| Patent arteriosus ductus and sepsis | N (%) | 10 (3.7) | 21 (7.2) | 1.59 (0.78, 3.24) | 0.203 |
Adjusted by gestational age and sex.
HD high dose, LD low dose, N number of patients, EN enteral nutrition.